ArticleAddiction (Abingdon, England)2010
'To prove this is the industry's best hope': big tobacco's support of research on the genetics of nicotine addiction.
Article in Addiction (Abingdon, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Nicotine-Mediated Redox and Nitrosative Stress in Cardiorenal Health.Hypertension (Dallas, Tex. : 1979) · 2026Review
- The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review.American journal of public health · 2018Article
- Unwarranted optimism in media portrayals of genetic research on addiction overshadows critical ethical and social concerns.Journal of health communication · 2015Article
- The tobacco industry, researchers, and ethical access to UK Biobank: using the public interest and public good.American journal of public health · 2014Article
- Article
- Tobacco and the invention of quitting: a history of gender, excess and will-power.Sociology of health & illness · 2013Article
- Addiction industry studies: understanding how proconsumption influences block effective interventions.American journal of public health · 2013Article
- Framing Nicotine Addiction as a "Disease of the Brain": Social and Ethical Consequences.Social science quarterly · 2012Article
- Integrating genetic studies of nicotine addiction into public health practice: stakeholder views on challenges, barriers and opportunities.Public health genomics · 2012Article
- Being more realistic about the public health impact of genomic medicine.PLoS medicine · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundNew molecular techniques focus a genetic lens upon nicotine addiction. Given the medical and economic costs associated with smoking, innovative approaches to smoking cessation and prevention must be pursued; but can sound research be manipulated by the tobacco industry? METHODOLOGY: The chronological narrative of this paper was created using iterative reviews of primary sources (the Legacy Tobacco Documents), supplemented with secondary literature to provide a broader context. The empirical data inform an ethics and policy analysis of tobacco industry-funded research.
findingsThe search for a genetic basis for smoking is consistent with industry's decades-long plan to deflect responsibility away from the tobacco companies and onto individuals' genetic constitutions. Internal documents reveal long-standing support for genetic research as a strategy to relieve the tobacco industry of its legal responsibility for tobacco-related disease.
conclusionsIndustry may turn the findings of genetics to its own ends, changing strategy from creating a 'safe' cigarette to defining a 'safe' smoker.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.